DcR3, TFF3, and Midkine Are Novel Serum Biomarkers in Small Intestinal Neuroendocrine Tumors

Publisher： Karger

E-ISSN： 1423-0194|105|2|170-181

ISSN： 0028-3835

Source： Neuroendocrinology, Vol.105, Iss.2, 2016-11, pp. : 170-181

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prognostic Significance of Lymph Node Metastases in Small Intestinal Neuroendocrine Tumors

By  

Neuroendocrinology, Vol. 101, Iss. 1, 2015-01 ,pp. : 58-65

Karger

Access to resources Recommend Favorite

Toward a Preoperative Classification of Lymph Node Metastases in Patients with Small Intestinal Neuroendocrine Tumors in the Era of Intestinal-Sparing Surgery

By  

Neuroendocrinology, Vol. 103, Iss. 5, 2015-10 ,pp. : 552-559

Karger

Access to resources Recommend Favorite

Ki-67 Index and Solid Growth Pattern as Prognostic Markers in Small Intestinal Neuroendocrine Tumors

By  

Neuroendocrinology, Vol. 102, Iss. 4, 2015-0 ,pp. : 327-334

Karger

Access to resources Recommend Favorite

Immunohistochemical Expression and Prognostic Value of ER, PR and HER2/neu in Pancreatic and Small Intestinal Neuroendocrine Tumors

By  

Neuroendocrinology, Vol. 93, Iss. 4, 2011-04 ,pp. : 249-258

Karger

Access to resources Recommend Favorite

A Nomogram to Assess Small-Intestinal Neuroendocrine Tumor (‘Carcinoid’) Survival

By  

Neuroendocrinology, Vol. 92, Iss. 3, 2010-08 ,pp. : 143-157

Karger

Access to resources Recommend Favorite